Cetera Advisor Networks LLC Corcept Therapeutics Inc Transaction History

Cetera Advisor Networks LLC

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$21.1 - $27.46 $368,089 - $479,039
17,445 New
17,445 $439,000
Q1 2021

May 17, 2021
SELL
$23.49 - $30.56 $238,587 - $310,397
-10,157 Closed
0 $0
Q4 2020

Feb 17, 2021
BUY
$16.78 - $27.3 $170,434 - $277,286
10,157 New
10,157 $266,000

Others Institutions Holding CORT

# of Institutions
347
Shares Held
86.6M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.01B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email